Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1764

1.
2.

The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.

Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS.

Eur J Gynaecol Oncol. 1998;19(3):203-8.

PMID:
9641214
3.

High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.

Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Garcia S, Campo E, Pahisa J, Ordi J.

Am J Obstet Gynecol. 2007 Oct;197(4):359.e1-6. Epub 2007 Aug 21.

PMID:
17714678
4.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

5.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326
6.
7.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

PMID:
12509400
9.

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.

Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J.

J Natl Cancer Inst. 2004 Feb 18;96(4):280-93.

PMID:
14970277
10.

Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system.

Nuovo GJ, Bartholomew D, Jung WW, Han IK, Um T, Grabarz DF, Lee DJ, McCabe RT.

Diagn Mol Pathol. 2008 Jun;17(2):107-11. doi: 10.1097/PDM.0b013e318161e4dd.

PMID:
18382353
11.
12.

Does the interval between papanicolaou tests influence the quality of cytology?

Jeronimo J, Khan MJ, Schiffman M, Solomon D; ALTS Group.

Cancer. 2005 Jun 25;105(3):133-8.

13.

Use of human papillomavirus testing in the management of atypical glandular cells.

Schnatz PF, Sharpless KE, O'Sullivan DM.

J Low Genit Tract Dis. 2009 Apr;13(2):94-101. doi: 10.1097/LGT.0b013e318183a438.

PMID:
19387129
14.

Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.

Bar-Am A, Gamzu R, Levin I, Fainaru O, Niv J, Almog B.

Gynecol Oncol. 2003 Oct;91(1):149-53.

PMID:
14529675
15.

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.

J Pathol. 2001 Oct;195(3):300-6.

PMID:
11673826
16.

Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.

Monsonego J, Bohbot JM, Pollini G, Krawec C, Vincent C, Merignargues I, Haroun F, Sednaoui P, Monfort L, Dachez R, Syrjänen K.

Gynecol Oncol. 2005 Oct;99(1):160-8.

PMID:
16023184
17.

DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia.

Lie AK, Risberg B, Borge B, Sandstad B, Delabie J, Rimala R, Onsrud M, Thoresen S.

Gynecol Oncol. 2005 Jun;97(3):908-15. Epub 2005 Apr 15.

PMID:
15943992
18.

Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.

Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, Rush BB, Demuth F, Schiffman M.

Cancer. 2002 Nov 15;95(10):2145-51.

20.

Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.

Almog B, Gamzu R, Kuperminc MJ, Levin I, Fainaru O, Niv J, Bar-Am A.

Gynecol Oncol. 2003 Mar;88(3):345-50.

PMID:
12648585

Supplemental Content

Support Center